Skip to content

Qorvo QRVO Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax

Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax at other companies

GATX logo
GATXGATX
-$39M-184%
MYR Group logo
MYR GroupMYRG
-$1.3M-1,168%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$138K-159%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$84K+158%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$25.18M-142%
Sysco logo
SyscoSYY
-$62M-146%

Other financials

Income statement

See full
Revenue$808.3M-7.0%
Gross profit$395.0M+7.8%
Operating income$31.5M+11.7%
Net income$29.7M-5.2%
EPS (diluted)$0.32-3.0%

Balance sheet

See full
Cash & equivalents$1.2B+19.4%
Total debt$1.6B-0.3%
Total equity$3.3B-1.4%
Total assets$5.8B-1.8%

Cash flow

See full
Operating cash flow$276.3M+38.7%
CapEx$21.2M-25.5%
Free cash flow$255.0M+49.4%

Valuation

See full
Market cap$8.66B+6.1%
Enterprise value$9.05B+2.9%
P/E25.6×-121×
P/S2.4×+0.2×

Profitability

See full
Gross margin45.9%+4.6pp
Operating margin11.2%+8.6pp
Net margin9.2%+7.7pp
FCF margin18.5%+5.4pp

Returns & leverage

See full
Return on equity10.1%+8.5pp
Debt / equity0.5×0.0×
Current ratio3.2×+0.5×

Where this comes from

Reported directly by Qorvo in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax.

The official record: Qorvo’s 10-Q, filed January 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Qorvo's other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Qorvo's other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax?
Qorvo (QRVO) reported other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax of $896K in Q4 2025.